Kalytera Therapeutics, Inc. announced changes to the company’s board of directors. Mr. Robin “Rob” Hutchison has joined the Board to fill the vacancy created by the resignation of Mr. Gary Leong, an independent director who also served on the Company’s Audit and Governance and Nominating Committees. Mr. Hutchison, who is an independent director, will also serve as a member of the company’s Audit, Compensation and Governance and Nominating Committees. Mr. Hutchison currently serves as President, CEO and Chairman of RMR Science Technologies, Inc. In 2007 Rob founded biOasis Technologies, and served as President, CEO and Executive Chairman of biOasis through December 2017. From 2013 – 2015 Mr. Hutchison also served as Executive Chairman of Biommune Technologies (now named Pascal Biosciences).